Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients
Clinical trial NCT01489566 · UNKNOWN
Trial details
- NCT number
- NCT01489566
- Sponsor
- Shenzhen Kangzhe Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.